Search

Your search keyword '"Abraham Acevedo-Arozena"' showing total 56 results

Search Constraints

Start Over You searched for: Author "Abraham Acevedo-Arozena" Remove constraint Author: "Abraham Acevedo-Arozena"
56 results on '"Abraham Acevedo-Arozena"'

Search Results

1. Corrigendum to 'TDP-43-M323K causes abnormal brain development and progressive cognitive and motor deficits associated with mislocalised and increased levels of TDP-43' [Neurobiology of disease Volume 193, April 2024, 106437]

2. TDP-43-M323K causes abnormal brain development and progressive cognitive and motor deficits associated with mislocalised and increased levels of TDP-43

3. Generation and analysis of innovative genomically humanized knockin SOD1, TARDBP (TDP-43), and FUS mouse models

4. Generation and analysis of innovative genomically humanized knockin SOD1, TARDBP (TDP-43), and FUS mouse models

5. Loss of Frrs1l disrupts synaptic AMPA receptor function, and results in neurodevelopmental, motor, cognitive and electrographical abnormalities

6. Novel gene function revealed by mouse mutagenesis screens for models of age-related disease

7. Transgenic and physiological mouse models give insights into different aspects of amyotrophic lateral sclerosis

8. Skeletal Muscle Modulates Huntington’s Disease Pathogenesis in Mice: Role of Physical Exercise

9. A comprehensive assessment of the SOD1G93A low-copy transgenic mouse, which models human amyotrophic lateral sclerosis

10. A nonsense mutation in mouse Tardbp affects TDP43 alternative splicing activity and causes limb-clasping and body tone defects.

11. Reducing Igf-1r levels leads to paradoxical and sexually dimorphic effects in HD mice.

12. Pridopidine Promotes Synaptogenesis and Reduces Spatial Memory Deficits in the Alzheimer’s Disease APP/PS1 Mouse Model

13. Opinion: more mouse models and more translation needed for ALS

14. Uses for humanised mouse models in precision medicine for neurodegenerative disease

15. Generation, quality control, and analysis of the first genomically humanised knock-in mice for the ALS/FTD genes SOD1, TARDBP (TDP-43), and FUS

16. EFL1 mutations impair eIF6 release to cause Shwachman-Diamond syndrome

17. Novel gene function revealed by mouse mutagenesis screens for models of age-related disease

18. Inhibition of the mTOR pathway: A new mechanism of β cell toxicity induced by tacrolimus

19. TDP-43 mutations increase HNRNP A1-7B through gain of splicing function

20. Skeletal Muscle Modulates Huntington’s Disease Pathogenesis in Mice: Role of Physical Exercise

21. Loss of Frrs1l disrupts synaptic AMPA receptor function, and results in neurodevelopmental, motor, cognitive and electrographical abnormalities

22. Mice with endogenous <scp>TDP</scp> ‐43 mutations exhibit gain of splicing function and characteristics of amyotrophic lateral sclerosis

23. A genetic modifier suggests that endurance exercise exacerbates Huntington's disease

24. Humanized mutant FUS drives progressive motor neuron degeneration without aggregation in 'FUSDelta14' knockin mice

25. Pramipexole reduces soluble mutant huntingtin and protects striatal neurons through dopamine D3 receptors in a genetic model of Huntington's disease

26. Genetic Screens in Neurodegeneration

27. A novel SOD1-ALS mutation separates central and peripheral effects of mutant SOD1 toxicity

28. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

29. IGF-1 receptor antagonism inhibits autophagy

30. Widespread RNA metabolism impairment in sporadic inclusion body myositis TDP43-proteinopathy

31. Tracking of Individual Mice in a Social Setting Using Video Tracking Combined with RFID tags

32. Analysis of Individual Mouse Activity in Group Housed Animals of Different Inbred Strains using a Novel Automated Home Cage Analysis System

33. Erratum

34. α-Synuclein levels modulate Huntington's disease in mice

35. SOD1 and TDP-43 animal models of amyotrophic lateral sclerosis: recent advances in understanding disease toward the development of clinical treatments

36. A comprehensive assessment of the SOD1G93A low-copy transgenic mouse, which models human amyotrophic lateral sclerosis

37. Dissecting TDP-43 gain- and loss-of-function in neurodegeneration

38. Investigating dysfunctional RNA processing in TDP-43 mouse mutants

39. Reducing Igf-1r levels leads to paradoxical and sexually dimorphic effects in HD mice

40. Otitis media in the Tgif knockout mouse implicates TGFβ signalling in chronic middle ear inflammatory disease

41. α-Synuclein levels affect autophagosome numbers in vivo and modulate Huntington disease pathology

42. Behavioral and other phenotypes in a cytoplasmic Dynein light intermediate chain 1 mutant mouse

43. α-Synuclein impairs macroautophagy: implications for Parkinson's disease

44. Deconstructing Gene Function through <scp>ENU</scp> Mutagenesis

45. Rilmenidine attenuates toxicity of polyglutamine expansions in a mouse model of Huntington's disease

46. Dynein mutations impair autophagic clearance of aggregate-prone proteins

47. A missense mutation in the mouse TDP-43 gene leads to a gain of TDP-43 mediated splicing function: Implications for neurodegeneration

48. P23 Investigating new mutant models of MND

50. α-Synuclein impairs macroautophagy: implications for Parkinson's disease

Catalog

Books, media, physical & digital resources